| 摘要 |
PCT No. PCT/CA95/00243 Sec. 371 Date Aug. 15, 1995 Sec. 102(e) Date Aug. 15, 1995 PCT Filed Apr. 27, 1995 PCT Pub. No. WO95/29683 PCT Pub. Date Nov. 9, 1995A method of clearing atherosclerosis comprising the step of administering to a patient, at least one dosage amount of a pharmaceutical composition comprising an effective non-toxic amount of each of a chelating agent, a non-steroidal anti-inflammatory drug (NSAID), an anti-oxidant and a form of hyaluronic acid, selected from hyaluronic acid, salts thereof, homologues, analogues, derivatives, esters, complexes, fragments and subunits.
|
